Lancome Paris Clarifique Bx-interceptor Topical Acne Clearing Treatment Liquid
Product Images NDC 51150-995

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lancome Paris Clarifique Bx-interceptor Topical Acne Clearing Treatment (NDC 51150-995). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sicos Et Cie, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 mL Carton (30 mL Carton)

30 mL Carton (30 mL Carton)
This text contains information about a skincare product with salicylic acid as the active ingredient for acne treatment. It provides directions for use, warnings about skin irritation and dryness, as well as a list of ingredients. The product is designed to clear acne blemishes and aid in skin healing. It is clinically tested to reduce blemishes, blackheads, and whiteheads. The formulation includes additional ingredients like niacinamide and azelaic acid derivative for skin tone-evening and brightening benefits. The product advises using sunscreen due to the presence of alpha hydroxy acid (AHA) and emphasizes avoiding contact with the eyes. The brand is Lancome Paris, and the product is part of their Clarifique line named BX-INTERCEPTORâ„¢. The text also includes contact information and directions on application along with a caution about skin sensitivity to the sun.*
FDA Label Image

Product (Product)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.